Americans are going to get a little healthier. President Trump cut deals with the drugmakers Eli Lilly and Novo Nordisk to increase access to obesity drugs in a major benefit to American public health.The agreements are a winwin- win -- good for consumers, good for the companies and good for Trump.One of the most irrational superstitions of our time is that Big Pharma, which has l...
To access content, please login or purchase a subscription.